Related Experiment Video
Updated: Jul 13, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Relation between serum calcium, phosphate, parathyroid hormone and 'nondipper' circadian blood pressure variability
Mehmet Kanbay1, Bunyamin Isik, Ali Akcay
1Department of Internal Medicine, Section of Nephrology, Fatih University Faculty of Medicine, Ankara, Turkey. mkanbay@fatih.edu.tr
Insights
Higher phosphate and parathyroid hormone (PTH) levels are linked to nondipper hypertension in patients with normal kidney function. This suggests a connection between mineral metabolism and abnormal blood pressure patterns, even without kidney disease.
Area of Science:
- Cardiology
- Nephrology
- Endocrinology
Background:
- Abnormal circadian blood pressure is linked to bone and mineral metabolism issues in renal disease.
- This association has not been previously reported in hypertensive patients with normal renal function.
Purpose of the Study:
- To investigate the association between serum phosphate, calcium, parathyroid hormone (PTH), and the calcium x phosphate (Ca x P) product with nondipper hypertension.
- To evaluate these factors in hypertensive patients with normal renal function and no PTH disorders.
Main Methods:
- 190 hypertensive patients with normal phosphate and PTH levels were enrolled.
- Inclusion criteria included a glomerular filtration rate (GFR) >60 ml/min and no history of calcium, phosphate, vitamin D medication, or hyperparathyroidism.
Main Results:
- Nondipper patients (60%) exhibited higher phosphate, Ca x P product, and PTH levels compared to dipper patients (40%).
- Parathyroid hormone (PTH) and phosphate were identified as independent predictors of nondipper hypertension.
Conclusions:
- A relationship exists between elevated phosphate, PTH, and Ca x P product and the risk of nondipping in hypertensive individuals.
- This finding highlights the importance of mineral metabolism in the development of abnormal circadian blood pressure profiles, even in the absence of renal disease.
Background And Aims:
In patients with renal disease, an association between abnormal circadian blood pressure profile and abnormalities in bone and mineral metabolism, including vascular calcifications, is well known. However, such a link has not yet been reported in hypertensive patients with normal renal function. We aimed to evaluate if higher serum phosphate, calcium, parathyroid hormone (PTH) level and the calcium x phosphate (Ca x P) product would be associated with a nondipper hypertension, in patients with normal renal function and without any PTH disorder.
Methods:
190 hypertensive subjects with the following inclusion criteria were enrolled: (1) normal phosphate and PTH levels; (2) glomerular filtration rate (GFR) >60 ml/min, and (3) no history of calcium, phosphate, vitamin D medication and hyperparathyroidism.
Results:
Of the total population, 76 patients (40%) were classified as dippers and 114 (60%) as nondippers. Nondipper patients had higher levels of phosphate (3.70 +/- 0.61 vs. 3.35 +/- 0.44 mg/dl, p = 0.001), Ca x P product (35.4 +/- 6.5 vs. 31.5 +/- 5.0, p = 0.001) and PTH (75.7 +/- 28.8 vs. 46.6 +/- 17.1 pg/ml, p = 0.000) compared to dipper patients. Independent predictors (multiple regression) for nondipper hypertension were PTH (beta = 0.43, p = 0.001) and phosphate (beta = 0.9, p = 0.03).
Conclusion:
We demonstrate a graded independent relation between higher levels of phosphate, PTH, Ca x P product and the risk of nondipping in hypertensive patients with an estimated GFR of >60 ml/min and normal mineral metabolism.
Related Concept Videos
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Skeleton and Calcium Homeostasis
Serum Studies: Renal Function Tests
Hypertension and Regulation of Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Chronic Kidney Disease III: Interprofessional Care